{
  "drugid": "RxNorm:10689",
  "drugname": "tramadol",
  "guidelinename": "CYP2D6, OPRM1, COMT, and Opioids",
  "url": "https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/",
  "guidelinepharmgkbids": [
    "PA166104996"
  ],
  "citations": [
    {
      "pmid": "22205192",
      "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype",
      "authors": [
        "Crews K R",
        "Gaedigk A",
        "Dunnenberger H M",
        "Klein T E",
        "Shen D D",
        "Callaghan J T",
        "Kharasch E D",
        "Skaar T C"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011
    },
    {
      "pmid": "24458010",
      "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update",
      "authors": [
        "Crews Kristine R",
        "Gaedigk Andrea",
        "Dunnenberger Henry M",
        "Leeder J Steve",
        "Klein Teri E",
        "Caudle Kelly E",
        "Haidar Cyrine E",
        "Shen Danny D",
        "Callaghan John T",
        "Sadhasivam Senthilkumar",
        "Prows Cynthia A",
        "Kharasch Evan D",
        "Skaar Todd C"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2014
    },
    {
      "pmid": "33387367",
      "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.",
      "authors": [
        "Crews Kristine R",
        "Monte Andrew A",
        "Huddart Rachel",
        "Caudle Kelly E",
        "Kharasch Evan D",
        "Gaedigk Andrea",
        "Dunnenberger Henry M",
        "Leeder J Steven",
        "Callaghan John T",
        "Samer Caroline Flora",
        "Klein Teri E",
        "Haidar Cyrine E",
        "Van Driest Sara L",
        "Ruano Gualberto",
        "Sangkuhl Katrin",
        "Cavallari Larisa H",
        "Müller Daniel J",
        "Prows Cynthia A",
        "Nagy Mohamed",
        "Somogyi Andrew A",
        "Skaar Todd C"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2021
    }
  ],
  "recommendations": [
    {
      "implications": {
        "CYP2D6": "n/a"
      },
      "drugrecommendation": "No recommendation",
      "classification": "No Recommendation",
      "phenotypes": {
        "CYP2D6": "Indeterminate"
      },
      "activityscore": {
        "CYP2D6": "n/a"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "n/a"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Reduced O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine opioid.",
      "classification": "Optional",
      "phenotypes": {
        "CYP2D6": "Intermediate Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "0.25"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "0.25"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Reduced O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine opioid.",
      "classification": "Optional",
      "phenotypes": {
        "CYP2D6": "Intermediate Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "0.5"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "0.5"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Reduced O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine opioid.",
      "classification": "Optional",
      "phenotypes": {
        "CYP2D6": "Intermediate Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "0.75"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "0.75"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Reduced O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing. If no response and opioid use is warranted, consider non-codeine opioid.",
      "classification": "Optional",
      "phenotypes": {
        "CYP2D6": "Intermediate Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "1.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "1.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Greatly reduced O-desmethyltramadol (active metabolite) formation leading to diminished analgesia."
      },
      "drugrecommendation": "Avoid tramadol use because of possibility of diminished analgesia. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Poor Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "0.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "0.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "2.5"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "2.5"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "2.75"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "2.75"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "3.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "3.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "4.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "4.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "≥3.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "≥3.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "≥3.25"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "≥3.25"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "≥3.5"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "≥3.5"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "≥3.75"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "≥3.75"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "≥4.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "≥4.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "≥5.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "≥5.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Increased formation of O-desmethyltramadol (active metabolite) leading to higher risk of toxicity"
      },
      "drugrecommendation": "Avoid tramadol use because of potential for toxicity. If opioid use is warranted, consider a non-codeine opioid.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Ultrarapid Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "≥6.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "≥6.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Expected O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Normal Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "1.25"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "1.25"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Expected O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Normal Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "1.5"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "1.5"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Expected O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Normal Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "1.75"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "1.75"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Expected O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Normal Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "2.0"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "2.0"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    },
    {
      "implications": {
        "CYP2D6": "Expected O-desmethyltramadol (active metabolite) formation"
      },
      "drugrecommendation": "Use tramadol label recommended age- or weight-specific dosing.",
      "classification": "Strong",
      "phenotypes": {
        "CYP2D6": "Normal Metabolizer"
      },
      "activityscore": {
        "CYP2D6": "2.25"
      },
      "allelestatus": {},
      "lookupkey": {
        "CYP2D6": "2.25"
      },
      "comments": "n/a",
      "population": "general",
      "genotypes": null
    }
  ],
  "genes": [
    "CYP2D6"
  ],
  "notesonusage": null,
  "cpicVersion": "v1.28.0",
  "source": "CPIC"
}